Researchers are meeting in New York this week to see what may come of a possible new AIDS vaccine. Though a public health benefit may be years away, the recent breakthrough in Thailand is encouraging for research investment. Joel Rose reports.
Tourists from the U.S. carry a bad rap for being the loud, obnoxious, "Ugly American." But as more Indians can afford to travel abroad, they're developing their own tourist notoriety. Raymond Thibodeaux reports.
World Bank President Robert Zoellick says central bankers around the globe haven't addressed risks when it comes to regulating the economy. He'll talk financial reform control in a speech today at Johns Hopkins University. Jennifer Collins reports.
Environmentalists and others are concerned over whether the president of the U.S. Chamber of Commerce can be an unbiased party on a big climate change debate because of his affiliation with Union Pacific. Steve Henn reports.
Abbot Laboratories will pay almost $7 billion for the pharmaceutical unit of Belgian company Solvay, a move which will help Abbot diversify its products. Alisa Roth explores this and other big pharma mergers going on lately.